231 related articles for article (PubMed ID: 9669991)
21. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
Beye A; Pindur G
Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
[TBL] [Abstract][Full Text] [Related]
23. Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.
Topaloglu R; Akierli C; Bakkaloglu A; Aydintug O; Ozen S; Besbas N; Ozcelik T
Clin Rheumatol; 2001; 20(4):259-61. PubMed ID: 11529632
[TBL] [Abstract][Full Text] [Related]
24. The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population.
Cumming AM; Keeney S; Salden A; Bhavnani M; Shwe KH; Hay CR
Br J Haematol; 1997 Aug; 98(2):353-5. PubMed ID: 9266933
[TBL] [Abstract][Full Text] [Related]
25. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
26. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.
Poort SR; Rosendaal FR; Reitsma PH; Bertina RM
Blood; 1996 Nov; 88(10):3698-703. PubMed ID: 8916933
[TBL] [Abstract][Full Text] [Related]
27. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
Van Rooden CJ; Rosendaal FR; Meinders AE; Van Oostayen JA; Van Der Meer FJ; Huisman MV
Haematologica; 2004 Feb; 89(2):201-6. PubMed ID: 15003896
[TBL] [Abstract][Full Text] [Related]
28. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
29. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
31. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.
Blom JW; Doggen CJ; Osanto S; Rosendaal FR
JAMA; 2005 Feb; 293(6):715-22. PubMed ID: 15701913
[TBL] [Abstract][Full Text] [Related]
32. The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency.
Castaman G; Tosetto A; Cappellari A; Ruggeri M; Rodeghiero F
Blood Coagul Fibrinolysis; 2000 Jun; 11(4):321-6. PubMed ID: 10847418
[TBL] [Abstract][Full Text] [Related]
33. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A.
Doggen CJ; Cats VM; Bertina RM; Rosendaal FR
Circulation; 1998 Mar; 97(11):1037-41. PubMed ID: 9531249
[TBL] [Abstract][Full Text] [Related]
34. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous polymerase chain reaction restriction fragment length polymorphism identification of the factor V Leiden allele and the prothrombin 20210A mutation.
Wisotzkey JD; Bell T; Monk JS
Diagn Mol Pathol; 1998 Jun; 7(3):180-3. PubMed ID: 9836075
[TBL] [Abstract][Full Text] [Related]
36. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients.
Leroyer C; Mercier B; Oger E; Chenu E; Abgrall JF; Férec C; Mottier D
Thromb Haemost; 1998 Jul; 80(1):49-51. PubMed ID: 9684784
[TBL] [Abstract][Full Text] [Related]
38. Genetic risk factors for venous thrombosis in the elderly in a case-control study.
Karasu A; Engbers MJ; Cushman M; Rosendaal FR; van Hylckama Vlieg A
J Thromb Haemost; 2016 Sep; 14(9):1759-64. PubMed ID: 27377285
[TBL] [Abstract][Full Text] [Related]
39. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
[TBL] [Abstract][Full Text] [Related]
40. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
